Drug interaction study for moderate-to-severe chronic pain
Part of Pain clinical trials.
This study tests how a new pain medication interacts with another pain drug. It aims to see if combining them is safe and how it affects pain relief in people with ongoing pain that is not caused by cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must have moderate to severe chronic pain (like back pain, shoulder inflammation, or muscle pain) for at least 3 months.
- Your pain score must be 4 or higher on a 0-10 scale.
- You must be in good general health with no major heart, lung, or mental health conditions.
- You must agree to use effective birth control during the study and for 3 months after.
- You must not have used certain medications, including opioids, within the past 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests how different pain medications together affect pain in people with chronic lower back pain. It aims to find safer, more effective combinations for pain relief.
This study tests a new experimental drug (HW243040) in healthy volunteers to see if it is safe and how the body handles it. It includes pain testing to measure how the drug works on pain.
This study tests an experimental drug called (2R,6R)-HNK given through an IV to see if it can reduce pain caused by heat in healthy volunteers. It will help researchers learn if this drug could be a future pain reliever.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.